Emergent BioSolutions Inc. 2026 Q1 - Results - Earnings Call Presentation
Emergent BioSolutions Inc. reported its Q1 2026 earnings, revealing an EPS of $0.21, which surpassed expectations by $0.46. The company recorded revenue of $156.10 million, a 29.75% year-over-year decline but still $11.10 million above estimates. These results were shared during an earnings call accompanied by a presentation detailing financial performance and business updates.
- ▪Emergent BioSolutions Inc. reported Q1 2026 EPS of $0.21, beating estimates by $0.46.
- ▪The company's revenue for Q1 2026 was $156.10 million, down 29.75% year-over-year.
- ▪Despite the revenue decline, the company outperformed revenue expectations by $11.10 million.
- ▪The earnings results were presented in a slide deck issued alongside the earnings call.
- ▪The financial data was released on May 2, 2026, following the quarter ended April 30, 2026.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4897704-emergent-biosolutions-inc-2026-q1-results-earnings-call-presentation"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
